|
Zebrafish models of human leukemia and sarcoma
|
Z01 BC 010549
|
$687,101
|
$343,551
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-03
|
$308,531
|
$104,901
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-03S1
|
$56,787
|
$8,518
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-03
|
$1,319,186
|
$197,878
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
TRICCS: Targeting Inattention in Childhood Cancer Survivors
|
1R03CA132570-01
|
$78,000
|
$39,000
|
Hardy, Kristina
|
DUKE UNIVERSITY
|
|
The Robert H.Lurie Comprehensive Cancer Center
|
3P30CA060553-13S5
|
$90,600
|
$2,718
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-14
|
$5,033,724
|
$151,012
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S1
|
$216,819
|
$6,505
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S2
|
$66,034
|
$1,981
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
The molecular role of lkaros in leukemogenesis
|
5R01CA104962-02
|
$203,388
|
$101,694
|
WINANDY, SUSAN
|
NORTHWESTERN UNIVERSITY
|
|
The Adverse Effect of Health on Personal Goal Pursuit in Adolescents with Cancer
|
5R03CA126337-02
|
$80,593
|
$12,089
|
Schwartz, Lisa
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
TEL-AML1 Transgenic Zebrafish Model of Human Leukemia
|
1K22CA120626-01
|
$161,858
|
$161,858
|
SABAAWY, HATEM
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Targeted therapy for 11q23 acute leukemias.
|
3R01CA098459-03S2
|
$93,107
|
$46,554
|
HEMENWAY, CHARLES
|
TULANE UNIVERSITY OF LOUISIANA
|
|
T(8;21) in Blood Cell Proliferation and Differentiation
|
5R01CA096735-05
|
$356,391
|
$89,098
|
ZHANG, DONG-ER
|
SCRIPPS RESEARCH INSTITUTE
|
|
Studies of Non-Ionizing Radiation-Related Cancer
|
Z01 CP010135
|
$1,043,074
|
$3,380
|
Inskip
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
Z01 CP010131
|
$1,766,702
|
$357,732
|
Ron
|
DCEG (NCI)
|
|
Studies of BCR/ABL Leukemogenesis in Mice
|
5R01CA090576-08
|
$286,110
|
$143,055
|
Van Etten, Richard
|
NEW ENGLAND MEDICAL CENTER HOSPITALS
|
|
Stanford University Cancer Center
|
1P30CA124435-01
|
$1,500,000
|
$15,000
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
St.Jude Children's Cancer Center Support Grant (CCSG)
|
3P30CA021765-29S2
|
$5,331,937
|
$693,152
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
St.Jude Children's Cancer Center Support Grant (CCSG)
|
3P30CA021765-29S3
|
$98,400
|
$12,792
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fai
|
Z01 BC 010692
|
$68,001
|
$13,600
|
Arthur, Diane
|
CCR (NCI)
|
|
Roles and Regulation of p53
|
5P01CA087497-07
|
$1,583,080
|
$79,154
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Role of PTPN11 Mutations in Myeloid Leukemogenesis
|
5R01CA104282-04
|
$265,033
|
$198,775
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Role of PBX Proteins in Hematopoiesis and Growth Control
|
5R01CA090735-07
|
$299,598
|
$299,598
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Role of Nucleophosmin in FA-evolved Leukemia
|
5R01CA109641-04
|
$289,623
|
$57,925
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES
|
5K08CA104882-04
|
$138,672
|
$138,672
|
BROWN, VALERIE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-03
|
$279,026
|
$69,757
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$6,946
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$3,791
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$226,938
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Ras Pathway Mutations in Human Leukemia
|
5K22CA113557-02
|
$149,175
|
$149,175
|
Loh, Mignon
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$218,801
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$168,400
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Postgraduate Training in Pediatric Oncology
|
5T32CA082086-08
|
$302,117
|
$75,529
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
|
5R37CA036401-24
|
$574,893
|
$574,893
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
PHARMACODYNAMICS OF ANTILEUKEMIC AGENTS IN CHILDREN
|
5R01CA078224-10
|
$480,447
|
$480,447
|
EVANS, WILLIAM
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
$373,943
|
Wayne, Alan
|
CCR (NCI)
|
|
PEDIATRIC CHTN--AIDS CANCER RESEARCH
|
3U01CA054021-15S2
|
$828,868
|
$99,464
|
QUALMAN, STEPHEN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Pediaric Oncology Research Training Program
|
2T32CA009351-29
|
$237,038
|
$35,556
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pathology and Biology of Leukemia Oncogenes
|
5R01CA055029-17
|
$373,311
|
$186,656
|
CLEARY, MICHAEL
|
STANFORD UNIVERSITY
|
|
Oxygen and Phototherapy in perinatal period: Risk of Acute Lymphoctyic Leukemia
|
1R03CA130030-01
|
$75,500
|
$75,500
|
PANETH, NIGEL
|
MICHIGAN STATE UNIVERSITY
|
|
Novel Ceramide-based Chemotherapy for Acute Leukemia
|
5R01CA100895-04
|
$236,830
|
$236,830
|
MAURER, BARRY
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
North American Juvenile Myelomonocytic Leukemia Project
|
5R01CA095621-05
|
$317,003
|
$317,003
|
EMANUEL, PETER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Myb protein specificity in human hematopoietic cells
|
5R01CA105257-03
|
$250,960
|
$25,096
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
Murine models of activated FLT3 receptor tyrosine kinase
|
5K08CA113434-02
|
$140,130
|
$49,046
|
LEE, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mouse model of infant acute megakaryocytic leukemia.
|
5K08CA111399-03
|
$134,379
|
$134,379
|
Raffel, Glen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-03
|
$231,698
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Pathways to Thymic Lymphoma and Leukemia
|
5P01CA109901-04
|
$1,958,333
|
$979,167
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Childhood Leukemia for this search: $44,502,817
|